Brief: Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
27/07/2026 13:31
BRIEF-Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer July 27 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
SAREPTA THERAPEUTICS APPOINTS MICHAEL SEVERINO, M.D., CHIEF EXECUTIVE OFFICER
SAREPTA THERAPEUTICS - DOUG INGRAM TO RETIRE AND SERVE AS ADVISOR UNTIL END OF 2026
Source text: ID:nBw5znLJpa
Further company coverage: SRPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sarepta Therapeutics
See all newsUS RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Sarepta, Dyne fall after Novartis muscle disorder trial failure